Literature DB >> 10489844

Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology.

C Dani1, M F Reali, G Bertini, L Wiechmann, A Spagnolo, M Tangucci, F F Rubaltelli.   

Abstract

Respiratory distress syndrome (RDS) and transient tachypnoea (TT) are the most frequent acute respiratory diseases in the newborn. This study investigated the risk factors for RDS and TT in newborn infants. A population of 63,537 newborns was enrolled in a 12-month survey in Italy, 734 (1.15%) affected by RDS and 594 (0.93%) affected by TT. Multivariate regression analysis of maternal and perinatal data and the calculation of odds ratios (with 95% confidence intervals) were performed. It was demonstrated that gestational age, birthweight, maternal age, elective and emergency caesarean section (CS), and male sex were risk factors for RDS, while gestational age, maternal diseases, twinning, birthweight, operative vaginal delivery, elective and emergency CS, and male sex were risk factors for TT. The data confirm previous reports and demonstrate that advanced maternal age is a risk factor for RDS, while ruling out maternal diseases as independent risk factors for RDS.

Entities:  

Mesh:

Year:  1999        PMID: 10489844     DOI: 10.1034/j.1399-3003.1999.14a26.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

1.  Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn.

Authors:  Annemarie Stroustrup; Leonardo Trasande; Ian R Holzman
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

Review 2.  Asthma in 10- to 13-year-olds: challenges at a time of transition.

Authors:  Noreen M Clark; Julia A Dodge; Lara J Thomas; Rebecca R Andridge; Daniel Awad; James Y Paton
Journal:  Clin Pediatr (Phila)       Date:  2010-08-19       Impact factor: 1.168

3.  Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study.

Authors:  A Burguet; M Kaminski; P Truffert; A Menget; L Marpeau; M Voyer; J C Roze; B Escande; G Cambonie; J M Hascoet; H Grandjean; G Breart; B Larroque
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

4.  The Incidence of Allergic Disorders in First Degree Relatives of Neonates with Transient Tachypnea of Neonate.

Authors:  Mojgan Safari; Behnaz Basiri; Mehdi Ghaeeni
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 5.  Factors relating caesarean section to persistent pulmonary hypertension of the newborn.

Authors:  Niralee Babooa; Wen-Jing Shi; Chao Chen
Journal:  World J Pediatr       Date:  2017-10-20       Impact factor: 2.764

6.  Serum Ischemia-Modified Albumin in Preterm Babies with Respiratory Distress Syndrome.

Authors:  Hasan Kahveci; Cuneyt Tayman; Fuat Laoğlu; Hüseyin Tugrul Celik; Nazan Kavas; Ömer Kılıç; Salih Aydemir
Journal:  Indian J Clin Biochem       Date:  2015-04-28

7.  Neonatal respiratory morbidity at term and the risk of childhood asthma.

Authors:  G C S Smith; A M Wood; I R White; J P Pell; A D Cameron; R Dobbie
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

8.  Pelvic floor consequences of cesarean delivery on maternal request in women with a single birth: a cost-effectiveness analysis.

Authors:  Xiao Xu; Julie S Ivy; Divya A Patel; Sejal N Patel; Dean G Smith; Scott B Ransom; Dee Fenner; John O L Delancey
Journal:  J Womens Health (Larchmt)       Date:  2010-01       Impact factor: 2.681

Review 9.  Recent Advances in Pathophysiology and Management of Transient Tachypnea of Newborn.

Authors:  Ziad Alhassen; Payam Vali; Lokesh Guglani; Satyan Lakshminrusimha; Rita M Ryan
Journal:  J Perinatol       Date:  2020-08-04       Impact factor: 2.521

10.  Epinephrine administration at birth prevents long-term changes in dopaminergic parameters caused by Cesarean section birth in the rat.

Authors:  Patricia Boksa; Ying Zhang
Journal:  Psychopharmacology (Berl)       Date:  2008-06-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.